"Caribou Biosciences Announces Closing of Upsized IPO"
"Caribou Biosciences, Inc., (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today the...
"Learning to Love G.M.O.s"
"On a cold December day in Norwich, England, Cathie Martin met me at a laboratory inside the John Innes Centre, where she works. A plant...
